Abilify, Risperdal Compete To Become First Antipsychotic Approved For Pediatric Schizophrenia
User fee date could be as early as June 21 for Johnson and Johnson subsidiary Janssen’s Risperdal, firm tells “The Pink Sheet” DAILY.
User fee date could be as early as June 21 for Johnson and Johnson subsidiary Janssen’s Risperdal, firm tells “The Pink Sheet” DAILY.